Works by Santiago-Walker, Ademi

Results: 3
    1
    2

    Dose-Finding Quantitative <sup>18</sup>F-FDG PET Imaging Study with the Oral Pan-AKT Inhibitor GSK2141795 in Patients with Gynecologic Malignancies.

    Published in:
    Journal of Nuclear Medicine, 2015, v. 56, n. 12, p. 1828, doi. 10.2967/jnumed.115.156505
    By:
    • Gungor, Hatice;
    • Saleem, Azeem;
    • Babar, Syed;
    • Dina, Roberto;
    • El-Bahrawy, Mona A.;
    • Curry, Ed;
    • Rama, Nona;
    • Chen, Michele;
    • Pickford, Emily;
    • Agarwal, Roshan;
    • Blagden, Sarah;
    • Carme, Sabin;
    • Salinas, Cristian;
    • Madison, Sam;
    • Krachey, Elizabeth;
    • Santiago-Walker, Ademi;
    • Smith, Deborah A.;
    • Morris, Shannon R.;
    • Stronach, Euan A.;
    • Gabra, Hani
    Publication type:
    Article
    3

    A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors.

    Published in:
    Investigational New Drugs, 2018, v. 36, n. 6, p. 1016, doi. 10.1007/s10637-018-0591-z
    By:
    • Aghajanian, Carol;
    • Bell-McGuinn, Katherine M.;
    • Burris, Howard A.;
    • Siu, Lillian L.;
    • Stayner, Lee-Ann;
    • Wheler, Jennifer J.;
    • Hong, David S.;
    • Kurkjian, Carla;
    • Pant, Shubham;
    • Santiago-Walker, Ademi;
    • Gauvin, Jennifer L.;
    • Antal, Joyce M.;
    • Opalinska, Joanna B.;
    • Morris, Shannon R.;
    • Infante, Jeffrey R.
    Publication type:
    Article